Prediction models for mortality in T2DM show considerable heterogeneity in methodology, performance and validation. Limited external validation and inconsistent calibration reporting highlight the need for robust, generalisable and transparently reported models to improve clinical risk stratification in diabetes care.
Kundu et al. (Wed,) studied this question.